Principal Financial Group’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $137K | Buy |
|
|||||
|
2025
Q2 | $122K | Buy |
|
|||||
|
2025
Q1 | $106K | Sell |
|
|||||
|
2024
Q4 | $144K | Sell |
|
|||||
|
2024
Q3 | $146K | Sell |
|
|||||
|
2024
Q2 | $266K | Sell |
|
|||||
|
2024
Q1 | $3.96M | Sell |
|
|||||
|
2023
Q4 | $6.74M | Buy |
|
|||||
|
2023
Q3 | $4.94M | Buy |
|
|||||
|
2023
Q2 | $305K | Buy |
|
|||||
|
2023
Q1 | $260K | Buy |
|
|||||
|
2022
Q4 | $266K | Buy |
|
|||||
|
2022
Q3 | $350K | Buy |
|
|||||
|
2022
Q2 | $213K | Sell |
|
|||||
|
2022
Q1 | $252K | Sell |
|
|||||
|
2021
Q4 | $608K | Buy |
|